MarketingRx: Biogen's new CEO talks DTC for depression drug candidate; AbbVie debuts Skyrizi TV ad for Crohn’s
New Biogen CEO Chris Viehbacher is already looking ahead to marketing and advertising strategies for zuranolone, Biogen’s major depressive disorder and postpartum candidate with partner …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.